Key result
Early all-off antithrombotics after LAAC linked to a ~12% higher rate of late DRT.
Why the study?
Device-related thrombus after left atrial appendage closure can occur, and the safety of early antithrombotic discontinuation guided by complete sealing is uncertain.
Does early antithrombotic discontinuation guided by complete sealing increase late device-related thrombus in patients after left atrial appendage closure?
Cohort (n=106)
Does early antithrombotic discontinuation guided by complete sealing increase late device-related thrombus in patients after left atrial appendage closure?
Early discontinuation of antithrombotics after LAAC based solely on complete sealing (PDL=0) may increase the risk of late device-related thrombus.
Background Device-related thrombus (DRT) after left atrial appendage closure (LAAC) can occur. Objective To evaluate late/very-late DRT after an institutional early "all-off" strategy guided by complete sealing (peri-device leak [PDL]=0). Methods We analyzed 106 consecutive successful LAAC procedures; 103 patients had evaluable imaging at 45 days (≥45 days). Per protocol, antithrombotics were discontinued at 45 days and/or 6 months if imaging showed PDL=0 and no DRT. Landmark analyses in patients free of 45-day DRT (n=101) compared late/very-late DRT (6–12 months) between all-off and continued-therapy groups. Results DRT occurred in 6/103 patients (5.8%): 2 at 45 days and 4 at 6–12 months. Late/very-late DRT occurred in 4/33 (12.1%) in the all-off group versus 0/68 (0.0%) in the continued-therapy group (p=0.010). A sensitivity analysis restricted to patients with PDL=0 and no 45-day DRT (n=44) showed a consistent direction (4/28 vs 0/16; p=0.280). Among patients with PDL=0 and no 45-day DRT who continued direct oral anticoagulants (n=8), the primary reason was recent ischemic stroke <6 months (6/8, 75%). Conclusion Reliance on PDL=0 alone to guide early complete withdrawal may be insufficient in selected patients; findings are hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (2026) conducted a cohort in Left atrial appendage closure (n=106). Early 'all-off' antithrombotic strategy vs. Continued antithrombotic therapy was evaluated on Late/very-late device-related thrombus (6-12 months) (p=0.010). An early 'all-off' antithrombotic strategy after left atrial appendage closure was associated with a higher rate of late device-related thrombus compared to continued therapy (12.1% vs 0.0%; p=0.010).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: